Oryzon Genomics S.A. (BME:ORY)
Spain · Delayed Price · Currency is EUR 2.786
-0.026 (-0.92%)
Apr 28, 2026, 2:29 PM CET
Oryzon Genomics Earnings Call Transcripts
Fiscal Year 2025
-
Key opinion leaders highlighted the urgent need for effective BPD treatments, with Vafidemstat showing rapid, significant improvements in agitation and aggression and a favorable tolerability profile. The drug’s novel mechanism and real-world trial design support its potential for approval and broader psychiatric application.